Markets:

Overview

News

Currencies

International

Treasuries

Poseida Therapeutics, Inc. - Common Stock (NQ:PSTX)

9.500 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 7, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Poseida Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories ↗

August 07, 2023

Benzinga

Via Benzinga

Poseida Therapeutics: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Looking Into Poseida Therapeutics's Return On Capital Employed ↗

March 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 31, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 23, 2023

Via Benzinga

Poseida Therapeutics Ushers New Era For Gene Therapies, Analyst Initiating Coverage Says ↗

January 04, 2023

Via Benzinga

Poseida Therapeutics Earnings Perspective: Return On Invested Capital ↗

December 22, 2022

Via Benzinga

Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 10, 2023

Gainers Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales.

Via Benzinga

Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 04, 2023

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...

Via Benzinga

Alibaba, XPeng, Dada Nexus And Some Other Big Stocks Moving Higher On Wednesday ↗

January 04, 2023

U.S. stocks traded mixed, with the Dow Jones dropping around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023 ↗

January 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 17, 2022

Gainers Cyclerion Therapeutics (NASDAQ:CYCN) shares increased by 10.8% to $0.39 during Monday's after-market session. The market value of their outstanding shares is at $16.8 million.

Via Benzinga

$7.5 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

August 11, 2022

The Dow Jones jumped by more than 500 points on Wednesday following inflation data for July. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Piper Sandler Maintains Overweight Rating for Poseida Therapeutics: Here's What You Need To Know ↗

August 09, 2022

Piper Sandler has decided to maintain its Overweight rating of Poseida Therapeutics (NASDAQ:PSTX) and raise its price target from $9.00 to $11.00. Shares of Poseida Therapeutics are trading up 1.08%...

Via Benzinga

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate ↗

August 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session ↗

August 04, 2022

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 04, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 04, 2022

Good morning! It's time for another dive into the biggest pre-market stock movers as we see what's affecting shares on Thursday!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 03, 2022

Gainers

Via Benzinga

Nasdaq Surges Over 300 Points; Moderna Earnings Beat Expectations ↗

August 03, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 300 points on Wednesday.

Via Benzinga

Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket ↗

August 04, 2022

Gainers Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 03, 2022

Via Benzinga

Poseida Therapeutics (PSTX) Stock Rockets 79% on Roche Deal ↗

August 03, 2022

Poseida Therapeutics (PSTX) stock is soaring on Wednesday after the clinical-stage biotechnology company announced a deal with Roche (RHHBY).

Via InvestorPlace

This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday ↗

August 04, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.

Via Benzinga

Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session ↗

August 03, 2022

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.

Via Benzinga

Dow Jumps 350 Points; Crude Oil Drops Over 2% ↗

August 03, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 350 points on Wednesday.

Via Benzinga

U.S. Stocks Are Trading Higher; ISM Services Index Rises Higher Than Expected ↗

August 03, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Wednesday.

Via Benzinga

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial ↗

August 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Poseida Shares Rally As Roche Takes Next Big Step Into Allogeneic CAR-T Field ↗

August 03, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 03, 2022

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Poseida Therapeutics, Inc. - Common Stock (NQ:PSTX)

Headline News about Poseida Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today